Do Health Technology Assessment organisations consider manufacturers' costs in relation to drug price? A study of reimbursement reports.
Cost Eff Resour Alloc
; 20(1): 46, 2022 Aug 31.
Article
em En
| MEDLINE
| ID: mdl-36045377
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Health_economic_evaluation
/
Health_technology_assessment
/
Prognostic_studies
/
Qualitative_research
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article